Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Misoprostol for Cervical Ripening Prior to Hysteroscopy
NCT06726278Completed
- Sponsor
- Hayatabad Medical Complex
- Start
- Aug 2022
- Primary completion
- Jul 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in infertility and Abnormal uterine bleeding (AUB) comparing Misoprostol Group with Placebo Group (2 arms). Primary endpoint: Amount of cervical dilation achieved on entry to hysteroscopy. Started Aug 2022; status: completed.
02
Drugs
misoprostol
03
Conditions
infertilityAbnormal uterine bleeding (AUB)
Beyond the preview
Go deeper on NCT06726278.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06726278.